Heliograph køber 10% kontrol over Glunz & Jensen

Den tyske konkurrent til Glunz & Jensen - Heliograph Holding AG har løbende købt aktier op i markedet og kunne i går meddele at de nu kontrollerede 10,2 % af aktierne. Dette gør selskabet til største aktionær efter Søren Stensdal med 14,8 %. Det er en meget spændende situation da G&J ligner en lækkerbisken for tyskerne at købe sig kontrol med - …

Read more.

---
Inrater version 1.25

Version 1.25 - New Q&A Feature & Support forum

Today we have released version 1.25 of InRater, which includes a new feature for premium clients. Now you can pose a question to our different fundmanagers. This has been a feature request from several of our loyal clients. You can access the Q&A section from the forum and is only available for paying clients. You can write in your own …

Read more.

---

Den bedste investering kan være den du ikke laver...

Donald Trump har sagt at den bedste investering nogen gange er den man ikke foretager. Warren Buffet har noteret at selvom investeringer i bilfirmaer har været historisk dårlige, så har trenden hele tiden været entydig i forhold til heste. Vi skulle bruge færre af dem. Derfor var heste en dårlig investering da de blev substitueret af biler. Så hvis man kunne shorte …

Read more.

The gateway to small- and midcap stocks in Scandinavia. Steen has more than 15 years hands-on expericence in analysing and investing in stocks. He is a weekly contributor and analyst in “Aktieugebrevet”, one of the leading sources of independent analysis in Denmark.

Peter Hildebrandt, also known as “Akademikeren”, has been investing for more than 17 years. Mainly invests in Undervalued technology and biotech stocks and is currently rotating towards dividend stocks in energy and shipping.

I’m a ten year veteran of biotechnology, and currently pursuing my MBA from UCLA.  I use my knowledge of the industry and business to make my investing decisions.  I look for small to mid-cap biotech companies with innovative research and buy into their company during clinical trials.

Andreas is providing stock tips with deep fundamental research behind each stock he recommends. He is privately a portfolio manager at his own Investment company where he Invest in stocks, options, CFD’s etc. with a balanced long/short approach.

Jacob’s approach is to search for that which is undervalued and where the discount to the intrinsic value provides a large margin of safety. He believes sectors that are either out of favor or in distress typically offer the best opportunities.